Evaluası Penggunaan Obat Pasıen Penyakıt Jantung Koroner Pasca Pemasangan Stent dı RSPAD Gatot Soebroto

Alika Khansa Adita; Wan Syurya Tri Dharma

doi:10.57174/j.born.v3i2.97

Authors

Alika Khansa Adita Fakultas Farmasi, Universitas 17 Agustus 1945 Jakarta, Jakarta Utara, DKI Jakarta, Kode Pos 14350, Negara Indonesia https://orcid.org/0009-0003-6934-1583
Wan Syurya Tri Dharma Universitas 17 Agustus 1945 Jakarta

DOI:

https://doi.org/10.57174/j.born.v3i2.97

Keywords:

medicine types, characteristics, medication use accuracies, coronary heart disease, stent

Abstract

Coronary Heart Disease (CHD) occurs when the coronary arteries are narrowed by a buildup of atheroma and fatty material in the walls. Stent placement is done to treat narrowed coronary arteries and an option if the patient has tried medication or lifestyle changes but fails to improve heart health and has blockages in the arteries. This study aims to evaluate the 4 medication usage accuracies, to determine the characteristics and medication usage profiles in CHD patients after stent placement at Gatot Soebroto Hospital. This research was conducted with analytical descriptive and retrospective data collection through medical records for the 2021 period. The sample used was 83 patients. The study resulted based on the characteristics the most patients with CHD after stent placement were aged <65 years with 57 patients (68.68%), and the most comorbid hypertension was 26 patients (31.32%). The medicine widely used in CHD patients after stent placement is a combination of aspirin and clopidogrel in as many as 70 patients (83.34%). The parameters of the medication usage accuracy, the right indication, the right medicine, the right dose, and the right patient resulted in 100% that the patient got the suitability for medication use. The results of the relationship between variables and medication use through SPSS showed that gender had a sig value of 0.051 (>0.005), age had 0.544 (>0.005), and risk factors had 0.167 (>0.005) means that there is no relationship in medication use.

Downloads

Download data is not yet available.

References

Kemenkes RI. Situasi kesehatan jantung. Pus data dan Inf Kementeri Kesehat RI [Internet]. 2014;3. Available from: http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/infodatin-jantung.pdf

British Heart Foundation. UK Circulatory Diseases Factsheet. Br Hear Found. 2021;(March):1–21.

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Vol. 145, Circulation. 2022. 18–114 p.

American Heart Association. What Is a Stent? ANSWERS by Hear [Internet]. 2017;2. Available from: https://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300452.pdf

Boston Scientific. Angioplasty and Stent Education Guide. Bost Sci Corp [Internet]. 2011; Available from: www.bostonscientific.com

Lestari RD, Dewi R, Sanuddin M. Evaluasi Penggunaan Obat Pada Pasien Penyakit Jantung Koroner Di Instalasi Rawat Inap RSUD Raden Mattaher Jambi. J Healthc Technol Med. 2020;6(1):54–61.

N.Taroreh G, Mpila D, Citraningtyas G. Evaluasi Penggunaan Obat Pada Pasien Dengan Penyakit. PHARMACONJurnal Ilm Farm. 2017;6(4):55–66.

D S, T S. Penyakit Jantung Koroner Pasca Intervensi Koroner Perkutan Di Rsupn Dr . Cipto Mangunkusumo Patterns of Drug Therapy in Patients Antithrombotic Coronary Heart Disease in Post Percutaneous Coronary Intervention At Rsupn Dr . Cipto Mangunkusumo Period Janua. 2015;8(2):1–5.

Indonesia DKR. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian Di Rumah Sakit. Jakarta: Departemen Kesehatan RI; 2016.

RI P. Peraturan Pemerintah Republik Indonesia No. 51 Tahun 2009 Tentang Pekerjaan Kefarmasian. 2009;2(5):255.

Cahyono T. Statistika Terapan & Indikator Kesehatan. 2018. Yogyakarta: Deepublish;

Kemenkes RI. Modul Penggunaan Obat Rasional Dalam Praktek. Modul Pengguna Obat Rasional. 2011;3–4.

American Heart Association. Coronary Artery Disease. Coron Artery Dis – From, Coron Hear Dis. 2018;

Wells BG, Dipiro JT, Schwinghammer TL, DiPiro C V. Pharmacoterapy Handbook 9th Edition. United State: McGraw-Hill Education. 2015. 1–4485 p.

Kemenkes.RI. Pusdatin Hipertensi. Infodatin [Internet]. 2014;(Hipertensi):1–7. Available from: https://www.google.co.id/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwjIzfDJsYPKAhVSA44KHUmSDasQFggZMAA&url=http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/infodatin-hipertensi.pdf&usg=AFQjCNHWLiHieCeL1Ksg4Tr_yx

Mahottama AA, Karmaya INM, Muliani. Prevalensi Hipertensi Pada Penderita Penyakit Jantung Koroner (Pjk) Di Rsup Sanglah Denpasar Maret – September 2019 Fakultas Kedokteran Universitas Udayana. J Med udayana. 2021;10(4):6–10.

Arnisam SW. Pengaruh Obesitas Terhadap Kejadian Penyakit Jantung Koroner (PJK) Di Puskesmas Darul Iman Aceh Besar. Vol. 7, Biology Education. 2019. p. 69–81.

AHA. What is Dual Antiplatelet Therapy? (DAPT). Answers by Hear [Internet]. 2017; Available from: https://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_493120.pdf

PERKI. Pedoman Tatalaksana Sindrom Koroner Akut Edisi Keempat. 2018.

Bittl JA, Laine L. Gastrointestinal Injury Caused by Aspirin or Clopidogrel Monotherapy Versus Dual Antiplatelet Therapy. Vol. 79, Journal of the American College of Cardiology. Elsevier Inc.; 2022. p. 129–31.

Gramedia PBIPK. MIMS Petunjuk Konsultasi (Versi Indonesia). 18.